• 1
    Fong Y, Sun R, Jarmagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229:790799.MEDLINE
  • 2
    Liang TJ, Jeffers LJ, Reddy KR, de Medina M, Parker T, Cheinquer H, Idrovo V, et al. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993; 18:13261333.MEDLINE
  • 3
    Di Bisceglie AM, Order SE, Klein JL, Waggoner JG, Sjogren MH, Kuo G, Houghton M, et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 1991; 86:335338.MEDLINE
  • 4
    National Cancer Institute. Screening for hepatocellular cancer—screening/detection-health professionals. See, last updated May, 2001.
  • 5
    Szilagyi A, Alpert L. Clinical and histopathological variation in hepatocellular carcinoma. Am J Gastroenterol 1995; 90:1523.MEDLINE
  • 6
    El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340:745750.MEDLINE
  • 7
    Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CGC, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000; 32:330335.
  • 8
    McMahon BJ, Bulkow L, Harpster A, Snowball M, Lannier A, Sacco F, Dunaway E, et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000; 32:842846.MEDLINE
  • 9
    Wong LL, Whitney ML, Severino P, Wong LM. Improved survival with screening for hepatocellular carcinoma. Liver Transpl 2000; 6:320325.MEDLINE
  • 10
    Colombo M. Early diagnosis of hepatocellular carcinoma in Italy. A summary of a Consensus Development Conference held in Milan, 16 November 1990, by the Italian Association for the Study of the Liver (AISF). J Hepatol 1992; 14:401403.MEDLINE
  • 11
    Bruix J, Sherman M, Llovet JM, Beaugrand E, Lencioni R, Christensen E, Burroughs A, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001; 35:421430.MEDLINE
  • 12
    Bergstrand CG, Czar B. Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest 1956; 8:174.
  • 13
    Masseyeff R, Bonet C, Drouet J, Sudaka P, Balanne C. Radioimmunoassay of alpha-fetoprotein: technique and serum levels in the normal adults. Digestion 1974; 10:1728.MEDLINE
  • 14
    Johnson PJ. The role of serum α-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 2001; 5:145159.MEDLINE
  • 15
    Masopust J, Kithier K, Radl J, Koutecky J, Kotal L. Occurrence of fetoprotein in patients with neoplasms and nonneoplastic diseases. Int J Cancer 1968; 3:364373.MEDLINE
  • 16
    Javadpour N. The role of biologic tumour markers in testicular cancer. Cancer 1980; 45:17551761.MEDLINE
  • 17
    McIntire KR, Waldmann TA, Moertel CG, Go VL. Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res 1975; 35:991996.MEDLINE
  • 18
    Bloomer TA, Waldmann TA, McIntire KR, Klastkin G. Serum alpha-fetoprotein levels in patients with non-neoplastic liver disease [abstract]. Gastroenterology 1973; 65:530.
  • 19
    Alpert E, Feller E. Alpha-fetoprotein in benign liver disease—evidence that normal liver regeneration does not induce AFP synthesis. Gastroenterology 1978; 74:856858.MEDLINE
  • 20
    Liaw YF, Tai DI, Chen TJ, Chu CM, Huang MJ. Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma. Liver 1986; 6:133137.MEDLINE
  • 21
    Bloomer JR, Waldmann TA, McIntire KR, Klatskin G. Alpha-fetoprotein in non-neoplastic hepatic disorders. JAMA 1975; 233:3841.MEDLINE
  • 22
    Delmont J, Kermarec J, Lafon J, Bonet C, Cassuto JP, Masseyeff R. Radioimmunoassay of α-fetoprotein: studies from patients suffering from hepatic diseases. Digestion 1974; 10:2939.MEDLINE
  • 23
    Silver HKB, Deneault J, Gold P, Thompson WG, Shuster J, Freedman SO. The detection of α1-fetoprotein in patients with viral hepatitis. Cancer Res 1974; 34:244247.MEDLINE
  • 24
    Bayati N, Silverman AL, Gordon S. Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C. Am J Gastroenterol 1998; 93:24522456.MEDLINE
    Direct Link:
  • 25
    Sackett DL, Haynes RB, Guyatt GH, Tugwell P. The interpretation of diagnostic data. In: SackettDL, HaynesRB, GuyattGH, TugwellP, editors. Clinical Epidemiology. A Basic Science for Clinical Medicine, 2nd ed. Boston: Little, Brown and Co, 1991: 69139.
  • 26
    Furui J, Furukawa M, Kanematsu T. The low positive rate of serum α-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma. Hepatogastroenterology 1995; 42:445449.MEDLINE
  • 27
    Peng YC, Chan CS, Chen GH. The effectiveness of serum α-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma. Hepatogastroenterology 1999; 46:32083211.MEDLINE
  • 28
    Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai ZH. Frequency of raised α-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. Br J Cancer 1994; 69:11571159.MEDLINE
  • 29
    Cedrone A, Covino M, Caturelli E, Pompilli M, Lorenzelli G, Villani MR, Valle D, et al. Utility of α-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 Western patients. Hepatogastroenterology 2000; 47:16541658.MEDLINE
  • 30
    Van Roey G, Fevery J, Van Steenbergen W. Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients. Eur J Gastroenterol Hepatol 2000; 12:6166.MEDLINE
  • 31
    Raedle J, Roth WK, Oremek G, Caspary WF, Zeuzem S. Alpha-fetoprotein and p53 antoantibodies in patients with chronic hepatitis C. Dig Dis Sci 1995; 40:25872594.MEDLINE
  • 32
    Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, Domenicali M, et al. Serum α-fetoprotein for diagnosis of hepatocellular in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001; 34:570575.MEDLINE
  • 33
    Child CG III, Turcotte JG. Surgery in portal hypertension. In: ChildCGIII, editor. The Liver and Portal Hypertension. Philadelphia: W.B. Saunders, 1964: 50.
  • 34
    Pugh RNH, Murray-Lyon IM, Dawson JJ, Pietroni NC, Williams R. Transection of the oesophagus for bleeding oesophaeal varices. Br J Surg 1973; 60:646649.MEDLINE
  • 35
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, et al. A model to predict survival in patients with end-stage liver diseases. Hepatology 2001; 33:464170.MEDLINE
  • 36
    Nguyen MH, Keeffe EB. Treatment of hepatocellular carcinoma. In: RustgiAK, CrawfordJ, editors. Gastrointestinal Cancer: A Companion to Sleisenger and Fordtran's GI and Liver Diseases, 1st ed. Philadelphia: W.B. Saunders, 2002.
  • 37
    Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a north American urban population. Hepatology 1995; 22:432438.MEDLINE
  • 38
    Trevisani F, D'Intino PE, Caraceni P, Pizzo M, Stefanini GF, Mazziotti A, Grazi GL, et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Difference between cirrhotic and non-cirrhotic Italian patients. Hepatology 1995; 75:22202232.
  • 39
    Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, Coderc E, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994; 20:6571.MEDLINE
  • 40
    Colombo M, de Franchis R, Del Ninno E, Sangiovani A, De Fazio C, Tommasini M, Donato MF, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991; 325:675680.MEDLINE
  • 41
    Curley SA, Izzo F, Gallipoli A, de Bellis M, Cremona F, Parisi V. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular carcinoma. Ann Surg 1995; 222:375383.MEDLINE
  • 42
    Solmi L, Primerano AMA, Lionello G. Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases. Am J Gastroenterol 1996; 91:11891194.MEDLINE
  • 43
    Sherman M. Alphafetoprotein: an orbituary. J Hepatol 2001; 34:603605.MEDLINE
  • 44
    Peterson MS, Baron RL. Radiologic diagnosis of hepatocellular carcinoma. Clin Liver Dis 2001; 5:123144.MEDLINE
  • 45
    Peterson MS, Baron RL, Marsh JW, Oliver JH III, Confer SR, Hunt LE. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 2000; 217:743749.MEDLINE